A role of insulin-like growth factor 1 in β amyloid-induced disinhibition of hippocampal neurons

Neuroscience Letters

Volumn 384, Issue 1-2, 2005, Pages 93-97

  Xing, Changhong ^a   Yin, Yanling ^b   Chang, Rui ^a   He, Xiangping ^a   Xie, Zuoping ^a  

^a TSINGHUA UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Amyloid; Aminobutyric acid; Inhibitory postsynaptic current; Insulin like growth factor 1; Whole cell patch clamp

Indexed keywords

4 AMINOBUTYRIC ACID; AMYLOID BETA PROTEIN[25-35]; SOMATOMEDIN C;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; DRUG EXPOSURE; HIPPOCAMPUS; HORMONE ACTION; IMMUNOCYTOCHEMISTRY; INHIBITORY POSTSYNAPTIC POTENTIAL; NERVE CELL CULTURE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; SYNAPTIC TRANSMISSION; WHOLE CELL;

AMYLOID BETA-PROTEIN; ANIMALS; CELL COUNT; DRUG INTERACTIONS; EMBRYO; FEMALE; GAMMA-AMINOBUTYRIC ACID; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; MALE; MEMBRANE POTENTIALS; NEURAL INHIBITION; NEURONS; PATCH-CLAMP TECHNIQUES; PEPTIDE FRAGMENTS; PREGNANCY; RATS; SYNAPTIC TRANSMISSION;

EID: 20444474427     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2005.04.063     Document Type: Article

References (20)

1. G.B. Baker, and G.P. Reynolds Biogenic amines and their metabolites in Alzheimer's disease: noradrenaline, 5-hydroxytryptamine and 5-hydroxyindole-3- acetic acid depleted in hippocampus but not in substantia innominata Neurosci. Lett. 100 1989 335 339
2. T.N. Behar, Y.X. Li, H.T. Tran, W. Ma, V. Dunlap, C. Scott, and J.L. Barker GABA stimulates chemotaxis and chemokinesis of embryonic cortical neurons via calcium-dependent mechanisms J. Neurosci. 16 1996 1808 1818
3. E. Carro, and I. Torres-Aleman The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease Eur. J. Pharmacol. 490 2004 127 133
4. E. Carro, J.L. Trejo, T. Gomez-Isla, D. LeRoith, and I. Torres-Aleman Serum insulin-like growth factor I regulates brain amyloid-beta levels Nat. Med. 8 2002 1390 1397
5. E. Cherubini, J.L. Gaiarsa, and Y. Ben-Ari GABA: an excitatory transmitter in early postnatal life Trends Neurosci. 14 1991 515 519
6. F.T. Crews, R. McElhaney, G. Freund, W.E. Ballinger Jr., and M.K. Raizada Insulin-like growth factor I receptor binding in brains of Alzheimer's and alcoholic patients J. Neurochem. 58 1992 1205 1210
7. A.J. Cross Serotonin in Alzheimer-type dementia and other dementing illnesses Ann. N.Y. Acad. Sci. 600 1990 405 415 (discussion 415-407)
8. S. Dore, S. Kar, and R. Quirion Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity Proc. Natl. Acad. Sci. U.S.A. 94 1997 4772 4777
9. S. Dore, S. Kar, W. Rowe, and R. Quirion Distribution and levels of [125I]IGF-I, [125I]IGF-II and [125I]insulin receptor binding sites in the hippocampus of aged memory-unimpaired and -impaired rats Neuroscience 80 1997 1033 1040
10. M.S. Evans, M.A. Collings, and G.J. Brewer Electrophysiology of embryonic, adult and aged rat hippocampal neurons in serum-free culture J. Neurosci. Methods 79 1998 37 46
11. S.A. Frautschy, A. Baird, and G.M. Cole Effects of injected Alzheimer beta-amyloid cores in rat brain Proc. Natl. Acad. Sci. U.S.A. 88 1991 8362 8366
12. L. Gasparini, W.J. Netzer, P. Greengard, and H. Xu Does insulin dysfunction play a role in Alzheimer's disease? Trends Pharmacol. Sci. 23 2002 288 293
13. P.R. Louzada, A.C. Lima, D.L. Mendonca-Silva, F. Noel, F.G. De Mello, and S.T. Ferreira Taurine prevents the neurotoxicity of beta-amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer's disease and other neurological disorders FASEB J. 18 2004 511 518
14. Y. Nagai, A. Ogasawara, and K. Heese The possible mechanisms of Abeta(1-40)-or Abeta(1-42)-induced cell death and their rescue factors Nippon Yakurigaku Zasshi 124 2004 135 143
15. K.J. Reinikainen, L. Paljarvi, M. Huuskonen, H. Soininen, M. Laakso, and P.J. Riekkinen A post-mortem study of noradrenergic, serotonergic and GABAergic neurons in Alzheimer's disease J. Neurol. Sci. 84 1988 101 116
16. A.E. Roher, J.D. Lowenson, S. Clarke, A.S. Woods, R.J. Cotter, E. Gowing, and M.J. Ball beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease Proc. Natl. Acad. Sci. U.S.A. 90 1993 10836 10840
17. M. Rossor, and L.L. Iversen Non-cholinergic neurotransmitter abnormalities in Alzheimer's disease Br. Med. Bull. 42 1986 70 74
18. C. Schneider, D. Risser, L. Kirchner, E. Kitzmuller, N. Cairns, H. Prast, N. Singewald, and G. Lubec Similar deficits of central histaminergic system in patients with Down syndrome and Alzheimer disease Neurosci. Lett. 222 1997 183 186
19. I. Torres-Aleman Serum growth factors and neuroprotective surveillance: focus on IGF-1 Mol. Neurobiol. 21 2000 153 160
20. B.A. Yankner, L.R. Dawes, S. Fisher, L. Villa-Komaroff, M.L. Oster-Granite, and R.L. Neve Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease Science 245 1989 417 420